Petros Family Wealth LLC Has $4.33 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Petros Family Wealth LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the first quarter, Holdings Channel.com reports. The fund owned 8,263 shares of the healthcare conglomerate’s stock after purchasing an additional 172 shares during the period. UnitedHealth Group comprises about 4.8% of Petros Family Wealth LLC’s holdings, making the stock its 3rd biggest position. Petros Family Wealth LLC’s holdings in UnitedHealth Group were worth $4,328,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. bought a new position in UnitedHealth Group during the fourth quarter valued at $1,914,740,000. Amundi lifted its position in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.4%

Shares of UnitedHealth Group stock opened at $300.85 on Tuesday. The firm’s 50 day moving average price is $353.44 and its 200-day moving average price is $460.22. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $272.91 billion, a P/E ratio of 12.60, a PEG ratio of 1.42 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the business earned $6.91 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.94%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Kristen Gil bought 3,700 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on UNH. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Barclays reduced their target price on shares of UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a research note on Monday, June 2nd. Truist Financial reissued a “buy” rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Finally, TD Securities reaffirmed a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $427.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.